GenoLogics Life Science Software announces a new Chief Executive Officer, former Creo Executive, Michael Ball.
GenoLogics, developers of proteomics laboratory information management system ProteusLIMS, is proud to announce the appointment of a new Chief Executive Officer, Michael Ball. Michael brings with him 18 years experience of technology and senior management experience, with a particular emphasis on business development, sales, marketing, operations and customer service in high growth environments. Michael has a sound knowledge of mergers, acquisitions and strategic partnerships as well as extensive international experience.
(PRWEB) September 15, 2004
GenoLogics Life Science Software announces a new Chief Executive Officer, former Creo Executive, Michael Ball.
Victoria, BC, Canada, September 13, 2004
GenoLogics, developers of proteomics laboratory information management system ProteusLIMS, is proud to announce the appointment of a new Chief Executive Officer, Michael Ball. Michael brings with him 18 years experience of technology and senior management experience, with a particular emphasis on business development, sales, marketing, operations and customer service in high growth environments. Michael has a sound knowledge of mergers, acquisitions and strategic partnerships as well as extensive international experience.
Previously, Michael has held VP positions at both Creo and Carmanah Technologies. Michael will work closely with company founder James DeGreef, who will move to the position of President. “I am excited to be a part of a growing company in an emerging market,” states Michael Ball, GenoLogics’ new CEO. “GenoLogics has developed an innovative software solution that addresses significant challenges within the life sciences market”.
ProteusLIMS has been featured in leading trade publications such as BioIT World and Genome Technology. GenoLogics clients include the Genome BC Proteomics Centre, Oregon Health Sciences University and the University of British Columbia.
“We are very excited about the growth potential of ProteusLIMS in both the academic and the commercial markets. We are confident that Michael Ball’s experience, leadership and vision will be instrumental in taking GenoLogics to the next level” adds James DeGreef.
ProteusLIMS - A data management solution for proteomics research labs
In proteomics, researchers are faced with enormous amounts of data and increasingly complex and disintegrated research instruments. GenoLogicsÂ’ ProteusLIMS manages data from all parts of the research process, as well as the research process itself, enabling higher productivity.
ProteusLIMS is designed to manage data generated in the emerging field of proteomics research, where scientists undertake complex studies of proteins to develop disease diagnostics and find new targets for drug development. ProteusLIMS is the first commercially available laboratory information management system that specializes in meeting the needs of proteomics researchers.
About GenoLogics
Headquartered in Victoria, BC, GenoLogics develops laboratory information management systems for the life sciences market, specializing in the emerging field of proteomics research. As proteomics technologies progress from the research lab into commercial drug and clinical diagnostics applications, GenoLogics is continuing to develop additional functionality in its software to meet these unique needs. To find out more about GenoLogics please visit www. genologics. com.
GenoLogics is a registered trademark of GenoLogics Life Sciences Software Inc.
For more information contact
Meriah Jamieson (250) 483-7011
Meriah. jamieson@genologics. com
Www. genologics. com
# # #
